EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $5 | -70.6% | 198 | -74.1% | 0.00% | -66.7% |
| Q3 2023 | $17 | +750.0% | 764 | +506.3% | 0.00% | – |
| Q2 2023 | $2 | -96.9% | 126 | -96.2% | 0.00% | -100.0% |
| Q1 2023 | $65 | -99.8% | 3,333 | +107.1% | 0.01% | +366.7% |
| Q3 2020 | $38,000 | -2.6% | 1,609 | -1.7% | 0.00% | -57.1% |
| Q1 2019 | $39,000 | – | 1,636 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |